Introduction
The retinoblastoma gene product, pRB, has been implicated as a major regulator of cell proliferation through its ability to suppress entry into S-phase (Goodrich et al., 1991; Qin et al., 1995) . Its activity appears to be downregulated at appropriate times during the cell cycle by hyperphosphorylation (Buchkovich et al., 1989; Chen et al., 1989; DeCaprio et al., 1989; Mihara et al., 1989; Nevins, 1992a) . Deletions and other mutations in the RB tumor suppressor gene have been proposed as causes for the loss of growth regulation in several classes of tumors (reviewed in Hamel et al., 1993) . pRB and related proteins p107 (Ewen et al., 1991; Zhu et al., 1993) and p130 (Hannon et al., 1993; Li et al., 1993; Mayol et al., 1993) contain two highly conserved domains, termed the A and B boxes or the`pocket', which are separated by a non-conserved spacer region. The speci®c roles of each member of the RB family in the cell cycle and growth arrest are still under study.
A major physiological target of these proteins is the E2F family of transcription factors Bandara et al., 1991; Chellappan et al., 1991; Cao et al., 1992; Cobrinik et al., 1993) which form heterodimers with members of the DP family and activate E2F-dependent transcription (Bandara et al., 1993; Helin et al., 1993b; Krek et al., 1993; Helin and Harlow, 1994) . E2F-speci®c binding sites have been identi®ed in promoters of several cellular genes, including c-myc, N-myc, c-myb, and those encoding dihydrofolate reductase, thymidine kinase, the cell cycle serine/threonine kinase Cdc2, E2F-1, p107 and pRB itself (Johnson et al., 1994; Neuman et al., 1994; Zhu et al., 1995b and reviewed in Nevins, 1992b) . pRB binds exclusively to E2F-1, 72, 73 and 74 Kaelin et al., 1992; Ivey-Hoyle et al., 1993; Lees et al., 1993; Moberg et al., 1996) via the`pocket' and a region towards the carboxy terminus (Qin et al., 1992; Hiebert, 1993) . RB family members bind to the activation domain of the E2F proteins (Flemington et al., 1993; Helin et al., 1993a, b) , thus blocking E2F transcription factor activity (Hamel et al., 1992; Hiebert et al., 1992; Flemington et al., 1993; Helin et al., 1993a,b) . p107 is believed to interact with E2F-4 (Beijersbergen et al., 1994; Ginsberg et al., 1994) , and p130 with E2F-4 and E2F-5 (Buck et al., 1995; Hijmans et al., 1995; Vairo et al., 1995) . Interactions between pRB and E2F proteins not only suppress transcriptional activation by E2F but also repress basal promoter activity (Weintraub et al., 1992 (Weintraub et al., , 1995 Zamanian and La Thange, 1993; Adnane et al., 1995; Bremner et al., 1995; Sellers et al., 1995) of a variety of cellular genes (Lam and Watson, 1993; Hsiao et al., 1994; Johnson et al., 1994; Neuman et al., 1994; Shimizu et al., 1995; Sugarman et al., 1995; Tommasi and Pfeifer, 1995; Zhu et al., 1995b; Zwicker et al., 1996) . Both p107 and p130 also form complexes during dierent stages of the cell cycle with heterodimers containing Cdk2 and either cyclin A or E which bind to the spacer region and the amino terminus of these proteins Devoto et al., 1992; Lees et al., 1992; Pagano et al., 1992a,b; Shirodkar et al., 1992) . The interaction of p107 with cyclin/Cdk complexes also appears to inhibit Cdk activity, inducing growth arrest (Zhu et al., 1995a) .
Cyclins have been found to be expressed in a distinct temporal manner linked with cell proliferation and progression through the cell cycle. D cyclins along with protein kinase binding partners Cdk4 and Cdk6 are expressed during G1 and are believed to phosphorylate and inactivate pRB (Hinds et al., 1992; Matsushime et al., 1992 Matsushime et al., , 1994 Dowdy et al., 1993; Ewen et al., 1993; Kato et al., 1993; Hatakeyama et al., 1994; Meyerson and Harlow, 1994) . Cyclin E expression is maximally induced at the G1/S boundary and cyclin A appears at the G1/S transition and peaks later in S phase Pagano et al., 1992a; Ohtsubo et al., 1995; Resnitzky and Reed, 1995) . Both of these cyclins interact with Cdk2 to form a heterodimer capable of complex formation with both p107 and p130 Faha et al., 1992; Lees et al., 1992; Hannon et al., 1993) . The cyclin A/Cdk2 complex can also regulate pRB function by interacting directly with E2F/ DP heterodimers (Dynlacht et al., 1994; Krek et al., 1994; Xu et al., 1994; Kitagawa et al., 1995) .
Previous work in our laboratory identi®ed a novel slowly-migrating E2F complex which appeared following dierentiation of mouse C2C12 cells into myotubes and which contained p130 and possibly one or more additional unidenti®ed proteins (Corbeil et al., 1995) . The present studies were undertaken to determine if this novel complex is present during the cell cycle. The results indicated that it is associated with growth arrest and may function in the G1/S transition.
Results

E2F complexes in cycling, serum-starved and dierentiated cells
Previous work by our laboratory using electrophoretic mobility shift assays (EMSA) demonstrated the appearance of a novel slowly-migrating functional E2F complex during muscle dierentiation of mouse C2C12 cells (Corbeil et al., 1995) . In this and the present study, the term functional E2F is meant to refer to heterodimers formed by members of the E2F and DP transcription factor families which interact with target E2F-speci®c DNA binding sites. As shown in Figure 1 , induction of myotube formation following incubation of C2C12 cells at low serum concentration led to the formation of a slowly-migrating E2F complex, termed C7 (lane 6), which was not present in proliferating undierentiated C2C12 cells (lane 5). Figure 1 (lane 5) shows that growing C2C12 cells contain additional E2F complexes which were demonstrated previously (Corbeil et al., 1995) to be composed largely of p107/E2F complexes. No complexes were detected using an unrelated or altered E2F-speci®c oligonucleotide in this or any of the studies described (data not shown). Little or no pRB/E2F complexes were detected in growing C2C12 mouse cells, although such complexes were demonstrated to exist in myotubes (Corbeil et al., 1995) . Growing C2C12 cells were also shown to contain high levels of free E2F which largely disappeared upon dierentiation (Corbeil et al., 1995) . Similar results are shown in Figure 1 in which the high levels of free E2F in growing cells (lane 5) are greatly reduced after dierentiation (lane 6). Although signi®cant levels of pRB/E2F complexes are present in myotubes, most E2F molecules were found to be associated with the third member of the pRB family, p130, in the form of the large C7 complex as well as two or more faster-migrating species (Corbeil et al., 1995) .
In the present studies we wished to determine if the pattern of E2F complex formation observed with myotube formation was related to terminal differentiation or to the arrest of cell proliferation associated with serum starvation. Studies were therefore carried out in CV-1 monkey kidney ®broblasts that do not differentiate following serum deprivation. Figure 1 shows that serum deprivation of CV-1 cells led to signi®cant changes in the patterns of E2F complexes and the levels of free E2F. A decrease was observed in the level of free E2F and at least one of the E2F complexes (see arrow) present in growing cells (compare lanes 1 and 2). In addition, serum starved cells (lane 2) contained a slowly-migrating E2F complex with migration properties similar to C7 in C2C12 myotubes which was absent in a asynchronously growing cells (lane 1). This type of complex was not observed in similar experiments using immortalized cell lines such as 143, Hela and L-cells (data not shown). It should also be noted that at least one major species (indicated by an asterisk in Figure 1 ) was present in all samples and migrated faster than free E2F. This species appeared to react non-speci®cally with the E2F-speci®c oligonucleotide as addition of a 100-fold excess of competing non-radioactive E2F-speci®c double-stranded oligonucleotide, which eliminated essentially all of the labeled material present in Figure 1 , had no eect on this faster-migrating species (data not shown).
To determine if the appearance of the C7-like complex is cell cycle regulated, CV-1 cells were treated with hydroxyurea and nocodazole to generate cell populations at the G1/S boundary, and in mitosis, respectively. The ecacy cell synchronization was con®rmed by FACS analysis (data not shown). CV-1 cells blocked in G1/S phase by hydroxyurea contained little or no C7-like E2F complex and the amount of free E2F was low (Figure 1, lane 3) . Mitotic CV-1 cells (Figure 1 , lane 4), contained high levels of the C7-like E2F complex and reasonably high levels of free E2F.
Analysis of E2F complexes in synchronized and serumstarved CV-1 cells
To analyse the composition of E2F complexes further, extracts from serum-starved, G1/S and mitotic CV-1 cells were studied by EMSA antibody`supershift' assays in which the eects on E2F complex formation of addition of antisera to various products known to interact with E2F were noted. Figure 2 shows that with extracts from serum-starved CV-1 cells, addition of anti-pRB polyclonal antibody 896 caused the`supershift' of E2F complexes (lane 2), indicating the presence of pRB/E2F complexes. Addition of monoclonal antibody SD9 (Santa Cruz) raised against p107 had no eect on the pattern, indicating that in such cells, p107/E2F complexes were not prominent. Polyclonal antibody C-20 (Santa Cruz) against p130 induced a`supershift' in the C7 E2F complex ( Figure  2, lane 4) . Thus, as with dierentiated C2C12 mouse cells, this slowly-migrating E2F complex appears to contain p130. Little eect was observed with antisera against cyclin A (lane 5) or Cdk2 (lane 6), indicating that E2F in serum-starved cells is not associated signi®cantly with either of these proteins. These results indicated that the patterns of E2F complexes found in serum-starved monkey CV-1 ®broblasts resembled those we observed in dierentiated mouse myotubes (Corbeil et al., 1995) , in that both contained little or no p107 complexes, but did possess pRB/E2F complexes and a novel slowly-migrating p130/E2F species. With extracts from G1/S (hydroxyurea-treated) and mitotic (nocodozole-treated) CV-1 cells ( Figure 2 , lanes 7 ± 12 and 13 ± 18, respectively), antibody`supershift' experiments revealed the same classes of complexes. Neither cell population contained signi®cant levels of E2F in association with p107 (lanes 9 and 15), cyclin A (lanes 11 and 17), or Cdk2 (lanes 12 and 18), as determined using SD9 anti-p107 serum, C160 antibodies against and mitotic cells contain pRB/E2F complexes and little or no p107/E2F species or E2F complexes containing Cdk2 or cyclin A. In addition, mitotic and serumarrested cells, but not those in G1/S, contained the large C7 p130/E2F complex.
Analysis of E2F complexes following serum stimulation of growth-arrested cells
To study the dynamics of E2F complex formation further, fresh fetal calf serum was added to serumstarved CV-1 cells and progression into the cell cycle was monitored by FACS analysis. The ®rst changes in E2F complexes were apparent two hours after serum induction. Figure 3a (lane 3) shows that the mobility of the C7 complex decreased slightly at 2 h, relative to C7 in serum-starved cells (lane 1), but returned to normal at 4 and 6 h (lanes 4 and 5), and then diminished greatly in amount by 12 h (lanes 6 to 9). This subtle change in mobility at 2 h has been noted in three separate experiments but its signi®cance remains unclear. Among the other E2F complexes, some loss of slower migrating material (see arrow) was observed at 2 h and then at 16 to 20 h. These same eects were observed in several separate experiments of this kind (not shown). In addition, the levels of free E2F began to rise following serum addition, reaching a maximum at about 6 to 12 h (lanes 5 and 6).
To correlate these biochemical changes with progression through the cell cycle, FACS analysis was performed in parallel for all of the cell populations studied in Figure 3a . Figure 3b and c show results obtained for selected critical times after serum addition. About 80% of serum-starved CV-1 cells were in Go/G1, with S-phase and G2/M cells comprising only 8 and 7%, respectively, of the total cell population. Little change in pattern was observed up to 12 h after which time the proportion of cells in S-phase increased to 26% at 16 h with a corresponding reduction in the number of cells in Go/G1, and no change in G2/mitotic cells. By 20 h, 32% of the cells were in S-phase and 23% had entered G2/mitosis, while less than half of the population were in Go/G1. By 24 h, the S-phase population had decreased slightly to 25%, whereas Go/G1 cells had increased to 50%, presumably due to passage into G2/M and back into Go/G1, respectively. These data indicated that a substantial fraction of the cell population responded and entered S-phase between 12 and 20 h following addition of fresh serum.
To study how serum addition aected the pattern of E2F complexes, extracts from cells harvested at two Figure 4 Analysis of E2F complexes following serum stimulation. Extracts from cells at 2 and 12 h following serum stimulation, as described in Figure 3a , were assessed for E2F complexes by EMSA. Extracts were either assayed directly or combined ®rst with various antibodies described in text. Lanes and antisera are as described in the Figure. The positions of free E2F species, C7 and other E2F complexes (C), and a background band (*) have been presented at the right. The positions of complexes that werè supershifted' by addition of various antibodies are indicated at the left times were studied in detail by antibody`supershift' EMSA. Two hours after addition of serum was chosen because this was the earliest time at which changes in the pattern of E2F complexes were observed, but prior to the onset of S-phase. Twelve hours was selected because by this time signi®cant numbers of cells had begun to enter S-phase. Figure 4 shows that E2F complexes in the G1 cells at 2 h for the most part resembled those in Go serum-starved cells. Treatment with 896 anti-pRB serum caused à supershift' of pRB/E2F complexes which were present in large amounts (lane 2). No E2F complexes were detected in association with p107 (lane 3), cyclin A (lane 5) or Cdk2 (lane 6). Treatment with C-20 antip130 antibodies (lane 4) revealed a major`supershifted' species presumably originating from the C7 complex which, as shown in Figure 3a (lane 3), was found to migrate slightly faster than C7 from serumstarved cells. In addition, a second faster-migrating supershifted' form was also detected at low levels which probably originated from a smaller p130/E2F complex that presumably migrated among the`other E2F complexes' in the absence of anti-p130 antibody. This complex, which was also seen in Figure 2 (lane 4) upon prolonged exposure, probably was composed of p130 and the E2F/DP heterodimer alone, as was the case found previously in C2C12 cells (Corbeil et al., 1995) . These results indicated that Go/G1 cells still contained p130/E2F and pRB/E2F complexes but that no p107/E2F/cyclin A/Cdk2 complexes had yet been produced. Figure 4 also shows that by 12 h several changes in E2F complexes were evident in this population highly enriched for S-phase cells. Treatment with 896 anti-pRB serum (lane 8) indicated the same pRB/E2F species. Lane 10 shows that virtually all of the p130/E2F complexes had disappeared as anti-p130 C-20 serum failed to yield the slowmigrating species characteristic of C7, and only a trace amount of the minor p130/E2F complex was detectable; however, these cells contained high levels of at least one p107/E2F complex (lane 9). In addition, anti-cyclin A (lane 11) and anti-Cdk2 (lane 12) antibodies also detected`supershifted' species presumably comprised of E2F associated with p107/ cyclin A/Cdk2 complexes. Thus S-phase was associated with the continued presence of pRB/E2F complexes, the disappearance of p130/E2F complexes, and the appearance of p107/E2F species, at least some of which were associated with cyclin A/ Cdk2.
Rb-related proteins in the cell cycle
To correlate changes in E2F complex formation with levels of pRB-related proteins, immunoblotting was performed on selected cell extracts. Equal amounts of extracts from asynchronous, serum-starved, hydroxyurea-treated, nocodazole-treated (as in Figure  1, lanes 1, 2, 3 and 4, respectively) and 12-h seruminduced CV-1 cells (as in Figure 3a , lane 6) were used for immunoblotting (see Figure 5 , lanes 1 to 5, respectively). Western blotting analysis of extracts using anti-pRB 245 monoclonal antibodies (Pharmingen) indicated that levels of pRB were quite high in all cells, indicating that no major dierences in synthesis or stability of this protein occurred during the cell cycle. However, dierences in migration on SDS ± PAGE indicated considerable variation in its state of phosphorylation. Serum-starved cells ( Figure 5 , lane 2) contained a single faster-migrating pRB species known to be hypophosphorylated and highly ecient in the inactivation of E2F-1, E2F-2, E2F-3, and E2F-4 (Templeton et al., 1991; Ewen et al., 1992; Dowdy et al., 1993; Kato et al., 1993; Matsushime et al., 1994; Mittnacht et al., 1994; Xu et al., 1994) . pRB from asynchronously growing (lane 1) and mitotic (lane 4) cells migrated more heterogeneously, suggesting the presence both hyper-and hypophosphorylated pRB species. Hydroxyurea-treated G1/S cells (lane 3) contained high levels of both hyper-and hypophosphorylated pRB whereas the predominantly S-phase cells present in 12-h serum-treated cultures (lane 5) contained exclusively the slowly-migrating inactive hyperphosphorylated form. As found previously (Buchkovich et al., 1989; Chen et al., 1989; DeCaprio et al., 1989; Mihara et al., 1989; Nevins, 1992a) , these results indicated that as cells emerge from Go/G1 into G1 and S-phase, pRB is converted from the poorly phosphorylated active form to a hyperphosphorylated inactive species. Entry into mitosis appeared to be accompanied by a decrease in phosphorylation, and thus presumably an increase in the ability to inactivate E2F. Both p107 and p130 also exhibited changes in gel mobility with progression through the cell cycle, however, the absolute levels of both also appeared to dier substantially at certain times. Serum-starved cells contained high levels of faster-migrating and thus hypophosphorylated p130, as measured by immunoblotting using C-20 anti-p130 antibody (lane 2). In G1/ S cells (lane 3) the level of p130 was greatly diminished and the very low amount that remained was exclusively Immunoblotting of pRB, p107, and p130. Cell extracts prepared from CV-1 cells growing asynchronously, treated by serum deprivation, hydroxyurea or nocodazole, or at 12 h following serum stimulation were separated by SDS ± PAGE and subjected to Western blotting analysis involving sera speci®c for pRB (896), p107 (C-18), or p130 (C-20), as described in Materials and methods. Lanes are as described in the Figure in the slowly-migrating and thus hyperphosphorylated form. The decrease in p130 levels could have resulted from decreased synthesis, increased turnover, decreased ability to interact with antibody, or a combination of any of these factors. Progression into S-phase was associated with an increase in p130 level (lane 5), but the p130 molecules were all hyperphosphorylated. In mitosis the migration pattern was much more heterogeneous, suggesting the accumulation of underphosphorylated p130 molecules. Figure 5 also shows that p107, as detected by immunoblotting with polyclonal anti-p107 antibody C-18 (Santa Cruz) raised against the last 18 amino acids of the carboxy terminus, appeared as several closely migrating species. Our laboratory had previously noticed that two or more species migrating in the position of p107 were capable of interacting with adenovirus type 5 E1A proteins (Corbeil et al., 1995) . It is possible that these species represent p107 molecules phosphorylated to varying degrees, or perhaps p107 and additional unidenti®ed pRB-related proteins. In both serumstarved and G1/S cells (lanes 2 and 3, respectively), which contained little or no p107/E2F complexes ( Figures 2 and 4) , only low levels of p107 were detected and this material was comprised largely of faster-migrating species. Progression into S-phase was accompanied by a signi®cant increase in the levels of p107 which was present largely as two slower-migrating hyperphosphorylated forms (lane 5). Entry into mitosis saw a distinct shift to underphosphorylated forms of p107 (lane 4).
Characterization of the novel slowly-migrating C7 E2F complex
Our laboratory has previously suggested that the novel slowly-migrating C7 E2F complex contains a large unidenti®ed protein in addition to p130 (Corbeil et al., 1995) . If such is the case, the most likely portions of p130 involved in interactions with this protein, apart from the N-terminal region, would be the spacer or the A and B box`pocket'. To determine if the spacer region of p130 in C7 complexes is occupied in complex formation with another protein, GST-cyclin A and GST-Cdk2 fusion proteins were combined with cell extracts in vitro and then the mixtures were analysed by EMSA. GST alone had no eect on the mobility of any of the E2F species (data not shown). Figure 6a shows that addition of GST-cyclin A alone to extracts from serum-starved CV-1 cells had little eect on the mobility of the C7 E2F complex or any other species (lane 2). Analysis of asynchronously growing CV-1 cells (lanes 5 to 8) was of less value because little C7 complex was present and no changes were observed under any conditions. However, addition of either GST-Cdk2 (lane 3) or a combination of GST-cyclin A and GST-Cdk2 (lane 4) caused a distinct shift in migration of C7 to a position termed C7*. Cdk2 is believed to interact with p130 and p107 as a heterodimer with either cyclin A or cyclin E Faha et al., 1992; Lees et al., 1992; Shirodkar et al., 1992; Li et al., 1993) . Thus either adequate amounts of one or both of these cyclins must have been present in the extracts to permit heterodimerization with GST-Cdk2, or Cdk2 alone was able to interact directly, as was implied by the cloning of p130
by the yeast two-hybrid method using Cdk2 alone as bait (Hannon et al., 1993) . The apparent non-reactivity of E2F complexes other than C7 in extracts from serum-starved cells (lanes 1 to 4), and all E2F complexes in those from asynchronously growing cells (lanes 5 to 8), probably resulted from the fact that the spacer regions of p130 and p107 were already occupied.
To study the nature of E2F complexes further, use was made of the 243-residue (243R) E1A protein of human adenovirus type 5 which is known to interact with all members of the pRB family (Moran and Mathews, 1987; Egan et al., 1988 Egan et al., , 1989 Whyte et al., 1988a Whyte et al., ,b, 1989 Barbeau et al., 1994) . The major binding site for all of these proteins resides at residues 123 ± 127 in CR2 (Egan et al., 1988; Whyte et al., 1989; Barbeau et al., 1994; Corbeil and Branton, 1994) ; however, interactions with sequences within CR1 (residues 40 ± 80) were shown to be responsible for release of E2F heterodimers from E1A/pRB family complexes (Ikeda and Nevins, 1993) . Thus deletion of CR1 sequences allows E1A proteins to interact with pRB-related species without disrupting the association with E2F. EMSA analyses were performed on extracts from serum-starved and asynchronously growing CV-1 cells to which had been added either the wild-type 243R E1A protein synthesized in vitro, E1A-243R from mutant dl38 ± 67 which lacks residues 38 to 67 in CR1, or dl38 ± 67 E1A protein plus mouse monoclonal antibody M58 (Harlow et al., 1985) which recognizes E1A products. Similar studies were also carried out with extracts from dierentiated mouse C2C12 myotubes which also contain a C7-like p130/E2F complex. Figure 6b shows that addition of E1A-243R to extracts from all cells caused the release of a considerable amount of free E2F (compare lanes 1 and 2, 5 and 6, and 9 and 10). With serum-starved CV-1 cells (Figure 6b, lanes 1 and 2) , disruption of most E2F complexes was apparent. However, a signi®cant proportion of the C7 complex, which varied somewhat from experiment to experiment, was resistant to disruption by E1A protein. Even addition of increasing amounts of E1A protein failed to eliminate this material (data not shown), suggesting that binding to the C7 complex was inecient. Release of free E2F and disruption of E2F complexes, including C7, were generally less ecient with the dl37 ± 61 CR1 E1A mutant than with wild-type E1A (Figure 6b, lane 3) . Addition of E1A-speci®c M58 antibodies (Figure 6b , lane 4) appeared to eliminate most of the fastermigrating E2F complexes, shifting their mobility to a position slightly slower than that of C7 (indicated as C* in the Figure) . Similar experiments using wild-type E1A protein and M58 produced little or no C8 complex (data not shown), thus con®rming that the dl37 ± 61 mutant E1A protein was able to bind to E2F complexes without dislodging E2F. It should be remembered that much of the C7 complex was unaected by either mutant or wild-type E1A protein. This eect was even more apparent in parallel studies in dierentiated mouse C2C12 cells. Figure 6b shows that addition of E1A protein disrupted most of the E2F complexes, but had little eect on C7 (compare lanes 9 and 10). Again, addition of mutant dl37 ± 61 E1A protein was somewhat less eective (lane 11), and addition of M58 antibodies yielded a C* complex that clearly migrated slightly slower than the relatively unaected C7 complex (lane 12). The failure of E1A products to interact eciently with the C7 complexes could be because the E1A binding sites on p130 molecules present in the C7 complex were not accessible, at least in the kind of in vitro binding assay just described. Thus it was possible that the`pocket' of p130 molecules present in C7 E2F complexes could be involved in complex formation with an additional unidenti®ed protein.
Discussion
E2F transcription factors are important cell cycle regulators as they control expression of several genes implicated in the onset of DNA synthesis. The precise roles of individual E2F species and members of the pRB family that regulate them are still being de®ned. In the present studies we examined E2F complexes from monkey CV-1 cells which were either growing asynchronously or serum starved, which were blocked in G1/S or mitosis by hydroxyurea or nocodozole, respectively, or which were stimulated by addition of fresh serum to enter the cell cycle following serum starvation. As summarized in Figure 7 , pRB/E2F complexes were present in similar amounts in all of the cells examined. As found previously, pRB was hypophosphorylated in growth-arrested and mitotic cells and most highly phosphorylated in S-phase (Nevins, 1992a) . The levels of pRB protein varied little, and thus it appears that E2F-1, 72, 73 and 74 which interact with pRB (Bardara et al., 1993; Helin et al., 1993a,b; Ivey-Hoyle et al., 1993; Lees et al., 1993; Helin and Harlow, 1994; Qin et al., 1995; Moberg et al., 1996) , do so throughout the cell cycle, and that regulation of these species may be largely dependent on phosphorylation of pRB. p107/E2F complexes were present in S-phase, but were undetectable at other times. In growth-arrested cells p107 protein was present at low levels and mostly in the hypophosphorylated form. The amounts of p107 increased following serum stimulation such that by S-phase, high levels of the highly phosphorylated form were present. Mitotic cells continued to contain high levels of p107 which appeared to be mostly underphosphorylated. Thus p107 appears to be regulated both by phosphorylation and by level of synthesis and/or protein stability. E2F complexes containing Cdk2 or cyclin A were only detected during S-phase, presumably largely in complexes containing p107. Regulation of 130 also appears to be by both phosphorylation and variations
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Serum starved Asynchronous Diff. C2C12 a b 1 2 3 4 5 6 7 8 9 10 11 12 Eect of adenovirus E1A protein on E2F complexes. E2F complexes present in serum-starved and asynchronous CV-1 cells and in terminally dierentiated mouse C2C12 myotubes were studied by EMSA as in Figure 1 , following addition of in vitro translated wild-type E1A-243R, dl37 ± 68 mutant E1A-243R, or dl37 ± 68 E1A protein and E1A-speci®c M58 antibody. Lanes are as described in the Figure. For both Figure 7a and b the positions of free E2F species, C7 and E2F complexes, and a background band (*) have been presented at the right and left as has that of C*, the E2F complexes which were`supershifted' by M58 serum in protein level. Growth-arrested cells contained high levels of p130 which existed mostly in the active hypophosphorylated form. Upon serum induction and entrance into G1 and S-phase, levels of p130 decreased and the small quantities of p130 molecules that remained were highly phosphorylated. Mitotic cells resembled those in growth arrest in that high levels of underphosphorylated p130 were present. Thus these data suggested that p130 and p107 may play speci®c and varied roles in regulating the cell cycle. p107 appears to function mostly during S-phase, although it may be rapidly inactivated by phosphorylation. p130 appears to be a major regulator of growth arrest as high levels appear following S-phase, and these p130 molecules are predominantly hypophosphorylated and therefore active. In addition to these types of regulation, p130 may regulate E2F activity by a third process dependent on formation the C7 complex.`Supershift' experiments described in Figure 4 demonstrated the presence of a fairly minor p130/E2F complex which migrated considerably faster than the large C7 p130/E2F complex. We have detected this type of complex previously at somewhat higher levels in mouse C2C12 cells (Corbeil et al., 1995) and in human MRC5 cells (unpublished data). As illustrated in Figure 7 , we believe that this minor, faster-migrating complex contains only p130 and the E2F/DP heterodimer. By far the predominant p130/E2F species was the large, slow-migrating C7 complex. C7 was prevalent in growth-arrested cells, diminished essentially completely during G1/S and S-phase, and appeared again during mitosis. We have made several attempts to identify the E2F species present in the C7 complex iǹ supershift' experiments employing antisera against human E2F-1, E2F-4 and E2F-5 (Santa Cruz). These sera reacted with free E2F but failed to recognize any of the E2F complexes in CV-1 cells (A Lai and PE Branton, unpublished results), and thus this question must be addressed using other approaches. While this manuscript was being prepared another group reported a p130/E2F complex with somewhat similar properties in rodent cell lines (Smith et al., 1996) . Why does the C7 complex migrate slower than the minor p130/E2F complex described above? In a previous study an apparently similar C7-like complex was identi®ed in terminally dierentiated muscle and neuronal cells and it was suggested that it contains additional E2F-or p130-binding proteins (Corbeil et al., 1995) . In an attempt to determine if p130 molecules present in C7 complexes are bound to additional polypeptides, experiments were conducted which tested the ability of p130 and other RB family members present in E2F complexes to interact in vitro with GST fusion products added exogenously. The results indicated that the spacer region of p130 in C7 complexes was unoccupied because GST-Cdk2 in combination with GSTcyclin A was able to bind to C7 and alter its migration pattern. Parallel experiments indicated that adenovirus E1A protein was able to disrupt all E2F complexes and release free E2F quite eciently, except for C7 which persisted and thus was fairly resistant to binding of E1A protein. These results suggested that the binding site on p130 with which E1A proteins interact may have been unavailable, perhaps because it was already occupied by the binding of an additional unidenti®ed polypeptide.
What could be the identity of this p130-binding protein in the C7 complex and what might be its function? E1A products are known to interact with the p130`pocket' utilizing primarily a region within CR2 containing the L-X-C-X-E core binding motif used by several other cellular and viral proteins known to interact with RB family members. A number of cellular proteins have been identi®ed which contain this binding motif and which have been observed to interact with RB family members, including RBP1 and RBP2 (Defeo-Jones et al., 1991; Kaelin et al., 1992; Fattaey et al., 1993; Otterson et al., 1993) , BRG1 and BRM (Dunaief et al., 1994; Strober et al., 1996) , and RIZ (Buyse et al., 1995) . Any or all of these proteins could be present in C7 complexes. The transient decrease in gel mobility of C7 observed following serum stimulation of growth-arrested CV-1 cells (Figure 3a ) may suggest that some changes in the composition of the C7 complex may take place and that a variety of proteins may occupy the E1A binding site on p130 depending on growth state or phase of the cell cycle. The function of additional p130-binding proteins in the C7 complex is unclear, but a number of possible roles can be suggested. It is possible that binding of the protein to the p130`pocket' decreases the potential for activation of E2F-4 or E2F-5 which associate with p130, either by aecting the stability of the interaction between p130 and E2F molecules, or by blocking binding of activating proteins such as the Dyson et al., 1989a Dyson et al., ,b, 1990 Dyson et al., , 1992 Egan et al., 1988 Egan et al., , 1989 Whyte et al., 1988a Whyte et al., , 1989 MuÈ nger et al., 1989; Davies et al., 1993) . Another possibility is that this protein functions directly to repress transcription from E2F-dependent promoters below basal level. Experiments are currently underway to identify the p130-binding protein in C7 complexes and to de®ne its biochemical function.
Materials and methods
Cell culture, synchronization and¯ow cytometry Mouse C2C12 cells (ATCC CRL 1772) were grown in Dulbecco's minimal essential medium (D-MEM) containing 20% fetal calf serum. Myoblast dierentiation into myotubes was induced by incubating C2C12 cells for 5 days in medium containing 5% horse serum, as described previously (Corbeil et al., 1995) . Monkey CV-1 cells (ATCC CCL 70) were grown in D-MEM containing 10% fetal calf serum. In many experiments CV-1 cells were induced to stop proliferating by incubation for 72 h in methionine-de®cient D-MEM containing 2% dialyzed calf serum. In some cases serum-starved CV-1 cells were stimulated to proliferate by addition of fresh D-MEM containing 10% fetal calf serum. In some experiments CV-1 cells were blocked at the G1/S boundary or in mitosis by treatment for 48 h in the presence of either 10 mM hydroxyurea or 40 ng/ml nocodazole, respectively. Cell populations were analysed by¯uorescence-activated cell sorting (FACS) following treatment with RNase and propidium iodide using a Becton-Dickinson FACScan.
Plasmids
The cDNAs for E1A 12S and mutant dl37 ± 68 were digested by HindIII and XbaI and cloned into pcDNA3. Large scale preparation of plasmids was performed as described in Sambrook et al. (1989) .
Preparation of cellular extracts
Cells were washed twice with phosphate buered saline (PBS), harvested by scraping, and collected by low speed centrifugation. Fresh or frozen cells were resuspended lysis buer (50 mM HEPES-KOH, pH 7.9, containing 0.4 M KCl, 0.1% (v/v) NP-40, 4 mM NaF, 4 mM NaVO 4 , 0.2 mM EDTA, 0.2 mM EGTA, 10% Glycerol (v/v), 1 mM DTT, 0.5 mM PMSF, 1 mg/ml pepstatin, 1 mg/ml leupeptin and 1 mg/ml aprotinin) and centrifuged for 45 min at 20 000 g.
In vitro translation
The coupled TnT Promega system was used for coupled in vitro transcription and translation in which about 1 ± 2 mg of plasmid DNA which had been ®rst linearized by restriction enzyme digestion was incubated in a 50 ml reaction mixture as described in the manufacturer's protocol.
Protein expression
GST-RB , GST-p107 (Shirodkar et al., 1992) , GST-130 (Corbeil et al., 1995) , GST-cyclin A and GST-Cdk2 (Tsai et al., 1991) fusion proteins were expressed in E. coli using appropriate constructs and protein products were puri®ed by the method of Smith and Johnson (1988) .
Antisera and immunoblotting
Puri®ed antisera against p107 (SD9 and C-18), p130 (C-20) and Cdk2 (M-2) were purchased from Santa Cruz Biotechnology, and anti-pRB serum G3-245 from Pharmingen. Polyclonal 896 serum raised against a synthetic peptide comprised of amino acids 896 ± 913 of human pRB protein was produced and provided by Peter Whyte (Corbeil et al., 1995) . C36 and C160 antibodies against pRB were obtained from mouse ascites¯uid produced by hybridoma cells generously given by Ed Harlow (Harlow et al., 1985) . ECL immunoblotting was performed using the conditions recommended by the manufacturer (Amersham).
Electrophoretic mobility shift assays E2F electrophoretic mobility shift assays (EMSA) were performed using whole cell extracts and the following E2F-speci®c or mutant oligonucleotides described previously by Cao et al., (1992): E2F GAT TTA AGT TTC GCG CCC TTT CTC AA MT GAT TTA AGT TTC GAT CCC TTT CTC AA Double stranded oligonucleotides were labeled using [a 32 P]dCTP and Klenow polymerase. Mobility shift assays were performed in 20 ml reaction mixtures containing 10 ± 20 mg of whole cell extract in 20 mM HEPES-KOH (pH 7.9) containing 40 mM KCl, 1 mM MgCl 2 , 0.1 mM EGTA, 0.4 mM DTT, 4 mg BSA, 2.5% (v/v) Ficoll, 1 ± 2 mg of salmon sperm DNA, and labeled probe containing 20 000 ± 50 000 c.p.m. Antibody`supershift' experiments were performed by incubating extracts with 1 ± 2 mg of the appropriate antibodies for 10 min on ice. In some cases in vitro translated or bacterially expressed proteins (500 ng) were ®rst added to the reaction and incubated on ice for 10 min. Mobility shift assay reactions were incubated at room temperature for 30 min and then samples were loaded on a 4% polyacrylamide gel (30:1) in 0.256TBE and subjected to electrophoresis at 200 V for 2 h. Gels were dried and analysed by autoradiography using Kodak X-omat ®lm.
